Fibroblast growth factor-like polypeptides

Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Hormones – e.g. – prolactin – thymosin – growth factors – etc.

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C530S300000, C530S350000, C424S198100

Reexamination Certificate

active

07459540

ABSTRACT:
The present invention provides novel Fibroblast Growth Factor-like (FGF-like) polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, antibodies and methods for producing FGF-like polypeptides. Also provided for are methods for the diagnosis and treatment of diseases associated with FGF-like polypeptides.

REFERENCES:
patent: 3773919 (1973-11-01), Boswell et al.
patent: 4179337 (1979-12-01), Davis et al.
patent: 4376110 (1983-03-01), David et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4892538 (1990-01-01), Aebischer et al.
patent: 4945050 (1990-07-01), Sanford et al.
patent: 4970154 (1990-11-01), Chang
patent: 5011472 (1991-04-01), Aebischer et al.
patent: 5106627 (1992-04-01), Aebischer et al.
patent: 5217889 (1993-06-01), Roninson et al.
patent: 5234784 (1993-08-01), Aslam et al.
patent: 5252714 (1993-10-01), Harris et al.
patent: 5272071 (1993-12-01), Chappel
patent: 5364791 (1994-11-01), Vegeto et al.
patent: 5489743 (1996-02-01), Robinson et al.
patent: 5557032 (1996-09-01), Mak
patent: 5589362 (1996-12-01), Bujard et al.
patent: 5593875 (1997-01-01), Wurm et al.
patent: 5635399 (1997-06-01), Kriegler et al.
patent: 5650298 (1997-07-01), Bujard et al.
patent: 5654168 (1997-08-01), Bujard et al.
patent: 5672510 (1997-09-01), Eglitis et al.
patent: 5676954 (1997-10-01), Brigham
patent: 5679559 (1997-10-01), Kim et al.
patent: 5811234 (1998-09-01), Roninson et al.
patent: 6150098 (2000-11-01), Zhang et al.
patent: 6639063 (2003-10-01), Edwards et al.
patent: 6716626 (2004-04-01), Itoh et al.
patent: 7259248 (2007-08-01), Itoh et al.
patent: 2001/0012628 (2001-08-01), Agarwal
patent: 2007/0128619 (2007-06-01), Itoh et al.
patent: 2007/0238657 (2007-10-01), Itoh et al.
patent: 0088046 (1983-09-01), None
patent: 133 988 (1985-03-01), None
patent: 143 949 (1988-10-01), None
patent: 154 316 (1989-09-01), None
patent: 36676 (1990-09-01), None
patent: 401 384 (1996-03-01), None
patent: 58481 (1996-10-01), None
patent: 505 500 (1997-07-01), None
patent: WO 91/09955 (1991-07-01), None
patent: WO 91/10425 (1991-07-01), None
patent: WO 91/10470 (1991-07-01), None
patent: WO 93/15722 (1993-08-01), None
patent: WO 94/20069 (1994-09-01), None
patent: WO 94/28122 (1994-12-01), None
patent: WO 95/05452 (1995-03-01), None
patent: WO 95/07178 (1995-03-01), None
patent: WO 95/34670 (1995-12-01), None
patent: WO 96/37609 (1996-11-01), None
patent: WO 96/40958 (1996-12-01), None
patent: WO 96/41865 (1996-12-01), None
patent: WO 97/31899 (1997-09-01), None
patent: WO 00/54813 (2000-09-01), None
patent: WO 01/18209 (2001-05-01), None
patent: WO 01/32678 (2001-05-01), None
patent: WO 01/36640 (2001-05-01), None
patent: WO 01/38357 (2001-05-01), None
patent: WO 01/49849 (2001-07-01), None
Ngo et al. Computational complexity, protein structure prediction, and the leventhal paradox 1994 pp. 491-495.
Skolnick et al. From genes to protein structure and function: novel applications of computational approaches in the geonmic era pp. 34-39 2000.
Go hunting in sequence databases but watch out for the traps 1996 vol. 12 No. 10pp. 425-427.
Protein annotation: detective work for function prediction 1998 vol. 14 No. 6.
Smith et al. The challenges of genome sequence annotation or the devil is in the details pp. 1222-1223 vol. 15 1997.
Bork et al. Powers and pitfalls in sequence analysis: The 70% hurdle pp. 398-400 2000.
Gaizie et al. Fibroblast growth factors and their receptors pp. 669-685 1997.
Bork et al. Predicting functions from protein sequences-where are the bottlenecks? pp. 313-318 vol. 18 1998.
Mikkelsen et al. Interpreting sequence motifs: a cautionary note vol. 9 No. 5.
Polejaeva et al., Theriogenology, vol. 53, pp. 117-126, 2000.
Rulicke et al., Experimental Physiology, 65, 6:589-601, 2000.
Bishop, Repro. Nutr. Dev., 36: 607-618, 1996.
Kennel, D.E., “Principles and practices of nucleic acid hybridization,” Progr. Nucl. Acid Res. Mol. Biol. 11: 259-301, 1971.
Goldfarb, M., “Functions of fibroblast growth factors in vertebrate development,” Cytokine & Growth Factor Rev. 7(4): 311-325, 1996.
Hu et al., “FGF-18, a novel member of the fibroblast growth factor family, stimulates hepatic and intestinal proliferation,” Mol. Cell. Biol. 18(10):6063-6074, Oct. 1998.
The ADHR Consortium. “Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23”Nature Genetics. 26:345-348 (2000).
Evans and McEnery. “Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder.”J Clin Endocrinol Metab82:674-681 (1997).
Nishimura et al., “Identification of a novel FGF, FGF-21, preferentially expressed in the liver(1).”Biochim Biophys Acta21:203-6 (2000).
Ghielli et al. “Regeneration processes in the kidney after acute injury: role of infiltrating cells.”Exp Nephrol6:502-7 (1998).
Webster. “Growth factors and myelin regeneration in multiple sclerosis.”Mult Scler3:113-20 (1997).
Ratajczak. “Fibroblast growth factors and early hemopoietic cell development.”Leuk Lymphoma27:221-9 (1997).
Yamaoka and Itakura. “Development of pancreatic islets (review).”Int J Mol Med3:247-61 (1999).
Hoppenreijs et al. “Corneal endothelium and growth factors.”Surv Ophthalmol41:155-64 (1996).
Kornmann et al. “Role of fibroblast growth factors and their receptors in pancreatic cancer and chronic pancreatitis.”Pancreas17:169-75 (1998).
Peus and Pittelkow. “Growth factors in hair organ development and hair growth cycle.”Dermatol Clin14:559-72 (1996).
Artuc et al. “Mast cells and their mediators in cutaneous wound healing—active participants or innocent bystanders?”Exp Dermatol8:1-16 (1999).
Ebadi et al. “Neurotrophins and their receptors in nerve injury and repair.”Neurochem Int30:347-74 (1997).
Cunha et al. “Keratinocyte growth factor as mediator of mesenchymal-epithelial interactions in the development of androgen target organs.”Semin Cell Dev Biol7:203-210 (1996).
Galzie et al. “Fibroblast growth factors and the receptors.”Biochem Cell Biol75:669-85 (1997).
Lewis et al. “Angiogenesis by gene therapy: a new horizon for myocardial revascularization?”Cardiovasc Res35:490-7 (1997).
Branch. “A good antisense molecule is hard to find.”Trends Biochem Sci23:45-50 (1998).
Verma and Somia. “Gene therapy—promises, problems and prospects.”Nature389:239-42 (1997).
Ledley. “Pharmaceutical approach to somatic gene therapy.”Pharm Res13:1595-614 (1996).
Faham et al. “Diversity does make a difference: fibroblast growth factor-heparin interactions.”Curr Opin Struct Biol8:578-86 (1998).
Podolsky. “Healing the epithelium: solving the problem from two sides.”J. Gastroenterol32:122-6 (1997).
Beck and Podolsky. “Growth factors in inflammatory bowel disease.”Inflamm Bowel Dis5:44-60 (1999).
Accession No. AB006136, Aug. 27, 1997, XP002165898.
Accession No. AQ175436, Sep. 21 1998, XP002188227.
Accession No. AV050323, Jun. 16, 1999, XP002165897.
Galzie Z. et al., “Fibroblast Growth Factors and their Receptors”, Biochemistry and Cell Biology, vol. 75, No. 6, 1997, pp. 669-685.
Smallwood P.M. et al., “Fibroblast Growth Factor (FGF) homologous factors: new members of the FGF family implicated in nervous system development”, Proceedings of the National Academy of Sciences of the USA, vol. 93, Sep. 1996 pp. 9850-9857.
Hull et al, “Healing with basic fibroblast growth factor is associated with reduced indomethacin induced relapse in a human model of gastric ulceration,” Gut, 40:204-10 (1997).
Hsu et al., “Heparin Is Essential for a Single Keratinoctye Growth Factor Molecule To Bind and Form a Complex with Two Molecules of the Extracellular Domain of Its Receptor,” Biochemistry, 38:2523-34 (1999).
Plotnikov et al., “Crystal

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Fibroblast growth factor-like polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fibroblast growth factor-like polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibroblast growth factor-like polypeptides will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4037096

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.